Search Results 61-70 of 1082 for ☆[텔레 : USIMHONDA2] 선불 유심 내구제 유심내구제정보 선불유심추천 선불폰소득 유심수익창출☆
About this study. Prospective observational drug registry developed to characterize the safety profile (including primarily potential serious hepatic risks) ...
To evaluate the effectiveness of Patisiran on ambulatory status in patients with hATTR amyloidosis with polyneuropathy who have a V122I or T60A mutation.
Publications. Mukhtar H, Iyer V, Demirel N, Bendel EC, Bjarnason H, Misra S. Embolotherapy for Pulmonary Arteriovenous Malformations in the Pediatric ...
Overview · Participation eligibility · Participating Mayo Clinic locations · More information ...
The goal of the study is to compare and evaluate safety and efficacy of tesevatinib 50mg versus placebo in patients with ADPKD. Participation eligibility.
The purpose of this study was to evaluate the safety and efficacy of revusiran (ALN-TTRSC) in patients with transthyretin (TTR) mediated Familial Amyloidotic ...
... information on other congenital malformations, syndromic diagnosis if available, demographic information, and to develop a biobank of DNA and white blood ...
Global Utilization and Registry Database for Improved Preservation of Donor Lungs · Overview · Participating Mayo Clinic locations · More information · Additional ...
The aim of this study is to deeply phenotype adult patients and healthy volunteers with varying degrees of sporadic CNS small vessel disease (deep white matter ...
Overview · Participation eligibility · Participating Mayo Clinic locations · More information · Additional contact information.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.